bioMérieux
Short position disclosed on July 29, 2026.
Evolution of the disclosed total
March 15, 2016 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since | Filing |
|---|---|---|---|---|---|
| Kintbury Capital LLP | 0.63% | new | July 29, 2026 | AMF |
In the United States BMXMF (OTC): 133,443 shares sold short on August 31, 2026. FINRA names no fund.
On the other side: the funds that hold bioMérieux Titelia
Get the moves on bioMérieux by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication | Filing |
|---|---|---|---|---|
| March 15, 2016 | Blackrock Institutional Trust Company, National Association | 0.51% | July 7, 2016 |
The AMF column opens the filing the fund itself lodged, on the regulator own site.
Download 51 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Ubisoft Entertainment 12.45% of the capital sold short
- Valeo 11.40% of the capital sold short
- Renault 9.27% of the capital sold short
- Viridien 8.39% of the capital sold short
- Teleperformance 7.30% of the capital sold short
- FDJ United 6.19% of the capital sold short
- Abivax 5.03% of the capital sold short
- Alstom 4.57% of the capital sold short
- Elis 4.57% of the capital sold short
- Rémy Cointreau 4.46% of the capital sold short
- VusionGroup 4.02% of the capital sold short
- Sopra Steria Group 3.90% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, bioMérieux, source AMF, data as at July 29, 2026, https://www.quivad.com/action/biomerieux?page=2